Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD and Safety of Leucostim vs Neupogen in Healthy Volunteers
NCT02725086Phase 1Completed
- Sponsor
- Dong-A ST
- Start
- Feb 2016
- Primary completion
- Apr 2016
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of filgrastim in neutropenia (2 arms), sponsored by Dong-A ST. Primary endpoints: Area Under the Curve to Infinity, Maximum Concentration and 2 more. Started Feb 2016; status: completed.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT02725086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02725086.